Table 2.
Summary of patient demography and medication, with log-transformed power values of the LF, HF, and TP bands
| All subjects (n = 91) | |
|---|---|
| Age (years) | 50.30 ± 15.25 |
| Sex (male/female) | 39/52 |
| Inpatient/outpatient | 21/70 |
| Duration of illness (years) | 19.28 ± 13.35 |
| Smoking (smoker/non-smoker) | 6/85 |
| BMI (kg/m2) | 24.01 ± 4.66 |
| CPZeqa (mg/day) | 491.21 ± 247.05 |
| BPDeqb (mg/day) | 0.78 ± 1.79 |
| DZPeqc (mg/day) | 7.62 ± 13.41 |
| PANSS total score | 72.16 ± 16.00 |
| lnLF (ms2) | 4.32 ± 1.12 |
| lnHF (ms2) | 3.81 ± 1.15 |
| lnTotal Power (ms2) | 4.93 ± 0.99 |
Data are presented as the mean ± standard deviation
BMI Body mass index, PANSS Positive and Negative Syndrome Scale, ln natural log-transformed, HF High frequency, LF Low frequency, TP Total power
a The daily dosages of antipsychotic drugs were converted to approximate chlorpromazine equivalents
b The daily dosages of anticholinergic antiparkinsonian drugs were converted to approximate biperiden equivalents
c The daily dosages of benzodiazepine were converted to approximate diazepam equivalents